111 related articles for article (PubMed ID: 18507042)
1. Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.
Han EK; Mcgonigal T; Butler C; Giranda VL; Luo Y
Anticancer Res; 2008; 28(2A):957-63. PubMed ID: 18507042
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo.
Sasaki T; Nakashiro K; Tanaka H; Azuma K; Goda H; Hara S; Onodera J; Fujimoto I; Tanji N; Yokoyama M; Hamakawa H
Biochem Biophys Res Commun; 2010 Aug; 399(1):79-83. PubMed ID: 20638364
[TBL] [Abstract][Full Text] [Related]
4. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.
Zitzmann K; Vlotides G; Brand S; Lahm H; Spöttl G; Göke B; Auernhammer CJ
Endocr Relat Cancer; 2012 Jun; 19(3):423-34. PubMed ID: 22499437
[TBL] [Abstract][Full Text] [Related]
5. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.
Frias MA; Thoreen CC; Jaffe JD; Schroder W; Sculley T; Carr SA; Sabatini DM
Curr Biol; 2006 Sep; 16(18):1865-70. PubMed ID: 16919458
[TBL] [Abstract][Full Text] [Related]
6. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
Lu X; Qian J; Yu Y; Yang H; Li J
Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells.
Shrivastav A; Varma S; Senger A; Khandelwal RL; Carlsen S; Sharma RK
J Pathol; 2009 Jul; 218(3):391-8. PubMed ID: 19360752
[TBL] [Abstract][Full Text] [Related]
8. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
[TBL] [Abstract][Full Text] [Related]
9. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol sensitivity of endogenous and myristoylated Akt.
Adam RM; Mukhopadhyay NK; Kim J; Di Vizio D; Cinar B; Boucher K; Solomon KR; Freeman MR
Cancer Res; 2007 Jul; 67(13):6238-46. PubMed ID: 17616681
[TBL] [Abstract][Full Text] [Related]
11. G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis.
New DC; Wu K; Kwok AW; Wong YH
FEBS J; 2007 Dec; 274(23):6025-36. PubMed ID: 17949438
[TBL] [Abstract][Full Text] [Related]
12. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
13. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
[TBL] [Abstract][Full Text] [Related]
14. The TRbeta1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells.
Verga Falzacappa C; Patriarca V; Bucci B; Mangialardo C; Michienzi S; Moriggi G; Stigliano A; Brunetti E; Toscano V; Misiti S
J Cell Biochem; 2009 Apr; 106(5):835-48. PubMed ID: 19160403
[TBL] [Abstract][Full Text] [Related]
15. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
McDaneld TG; Spurlock DM
J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
[TBL] [Abstract][Full Text] [Related]
16. Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells.
Kim CK; Nguyen TL; Lee SB; Park SB; Lee KH; Cho SW; Ahn JY
Exp Cell Res; 2011 Apr; 317(7):966-75. PubMed ID: 21182834
[TBL] [Abstract][Full Text] [Related]
17. A novel 165-kDa Golgin protein induced by brain ischemia and phosphorylated by Akt protects against apoptosis.
Ran R; Pan R; Lu A; Xu H; Davis RR; Sharp FR
Mol Cell Neurosci; 2007 Nov; 36(3):392-407. PubMed ID: 17888676
[TBL] [Abstract][Full Text] [Related]
18. Differential activation of CREB by Akt1 and Akt2.
Kato S; Ding J; Du K
Biochem Biophys Res Commun; 2007 Mar; 354(4):1061-6. PubMed ID: 17276404
[TBL] [Abstract][Full Text] [Related]
19. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
20. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells.
Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH
Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
